Arjo AB (0HQ8) Share Price & Analysis
0HQ8 Stock Chart & Stats
- Day’s Range
- SEK 33.62 - SEK 33.86
- 52-Week Range
- SEK 23.80 - SEK 34.12
- Previous Close
- SEK 33.72
- Volume
- 2,993
- Average Volume (3M)
- 23.92K
- Market Cap
- SEK 9.18B
- Enterprise Value
- SEK 12.01B
- Total Cash (Recent Filing)
- SEK 858.00M
- Total Debt (Recent Filing)
- SEK 5.35B
- Price to Earnings (P/E)
- 25.4
- Beta
- 0.72
- Next Earnings
- Jan 28, 2027 (Est.)
- EPS Estimate
- 0.6
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.57%
Bulls Say, Bears Say
Bulls Say
Structural Care Demand
Underlying demand is supported by a growing number of patients requiring care, which can make Arjo’s products relevant across economic cycles. This structural need, combined with its focus on acute and long-term care, supports durable market opportunity and recurring replacement and service demand.
Global Operating Platform
Arjo’s established international platform provides broad customer access, operational scale, and diversification across healthcare markets. Its presence in more than 100 countries and focus on multiple care settings can support product adoption, service reach, and resilience as regional demand patterns vary.
Cash Flow And Leverage
Current cash generation and improving leverage provide financial flexibility to support operations, investment, and strategic initiatives. Stronger free cash flow also gives Arjo more capacity to manage restructuring, fund commercial priorities, and reduce balance-sheet pressure over the medium term.
Bears Say
Compressed Profitability
Profitability remains materially below prior years, limiting the earnings produced from Arjo’s revenue base and equity capital. Lower margins can reduce resilience to cost inflation or pricing pressure, while modest ROE suggests the company is not yet converting its capital base into returns as efficiently as before.
Restructuring Burden
The operating-model changes require substantial restructuring and role reshuffling, creating execution demands and near-term cost pressure. Although intended to improve EBIT over time, the transition could distract management, disrupt processes, and delay the realization of the planned benefits during the coming 18 months.
Uneven Cash Durability
Recent cash generation is strong, but the historical record shows meaningful volatility and incomplete conversion of accounting earnings into free cash flow. That unevenness can constrain internally funded investment and makes future cash performance more dependent on working capital and operating execution.
0HQ8 FAQ
What was Arjo AB’s price range in the past 12 months?
What is Arjo AB’s market cap?
When is Arjo AB’s upcoming earnings report date?
How were Arjo AB’s earnings last quarter?
Is Arjo AB overvalued?
Does Arjo AB pay dividends?
What is Arjo AB’s EPS estimate?
How many shares outstanding does Arjo AB have?
What happened to Arjo AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Arjo AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Arjo AB
Arjo AB (publ) is a global leader in providing medical devices and innovative solutions tailored for patients experiencing limited mobility and age-related health conditions. Operating across North America, Western Europe, and other international markets, the company's comprehensive offerings span safe patient handling, hygiene and disinfection products, specialized medical beds, and technologies for the prevention and treatment of pressure injuries, leg ulcers, deep vein thrombosis, and edema. They also supply equipment for obstetric and cardiac diagnostics. Complementing its product range, Arjo delivers valuable services such as specialized room assessments for dementia and bariatric care, clinical consulting, equipment maintenance, and flexible rental and financing options. Their diverse client base comprises both private and public institutions engaged in acute and long-term healthcare. Founded in 1957, Arjo AB (publ) is headquartered in Malmö, Sweden.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andreas Elgaard
- Employees
- 7,000
- Website
- www.arjo.com
- Address
- Hans Michelsensgatan 10, Malmö, SN, 201 20, SE
Arjo AB (0HQ8) Earnings & Revenues
0HQ8 Company Deck
0HQ8 Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive, supported by 6% organic growth, stronger gross profit and adjusted EBIT, improved reported margins, higher operating cash flow, and lower leverage. Management also highlighted strong momentum in patient handling, North America, and Europe, along with a SEK 350 million EBIT improvement plan. Offsetting issues included higher restructuring costs, weaker quarterly performance in international and distributor-led markets, less favorable working capital, negative investment cash flow, revaluation losses, and uncertainty around the flu season's effect on the fourth quarter.
View all GB:0HQ8 earnings summaries0HQ8 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 1 | 6 |
| Technical Analysis | 3 | 1 | 6 |
| Moving Averages | 12 | 0 | 0 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| SE:ALIF.BAddLife AB | ||
| SE:XVIVOXvivo Perfusion AB | ||
| SE:BACTI.BBactiguard Holding AB | ||
| SE:SEDANASedana Medical AB | ||
| SE:ASKERAsker Healthcare Group AB |











